International Ophthalmology

http://link.springer.com/journal/10792

List of Papers (Total 59)

Aflibercept versus ranibizumab for treating persistent diabetic macular oedema

The purpose of this study was to compare the efficacy of intravitreal aflibercept versus ranibizumab for treating therapy-resistant diabetic macular oedema (DME). A 69-year-old man presented with persistent bilateral DME despite previous ranibizumab treatment. Bilateral study treatment comprised one cycle of three monthly ranibizumab injections (0.5 mg), followed by one cycle of ...